Anti-CD19 (Research Grade Denintuzumab Biosimilar) sinobiological 68215-H001

$714.00
In stock
SKU
68215-H001
Catalog No.SizePrice (USD)
68215-H001-55 mg$740.55
68215-H001-2525 mg$2,221.66
68215-H001-500500 µg$222.17

General Information

Product nameAnti-CD19 (Research Grade Denintuzumab Biosimilar)
Species reactivityReacts with: Human
SpecificityCD19
PreparationThis product is a recombinant monoclonal antibody expressed from HEK293 cells.
SourceIgG1, Kappa
PurificationProtein A
FormulationHistidine and Arginine buffer containing 120mM NaCl, 0.02% Tween 80, pH6.0
ConjugateUnconjugated
Endotoxin≦ 1 EU/mg
FormLiquid
ShippingThis antibody is shipped as liquid solution at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
StorageAntibody products are stable for twelve months from date of receipt when stored at -20℃ to -80℃. Preservative-Free. Avoid repeated freeze-thaw cycles.

Image / Experimental Information

Image 1 Description≥95 % as determined by SDS-PAGE.
Image 1 Alt TextHuman CD19-Denintuzumab Enzyme linked immunosorbent assay (ELISA) 46175
Image 1 URLSource image
Image 2 Description≥95 % as determined by SDS-PAGE.
Image 2 Alt TextHuman CD19-Denintuzumab Enzyme linked immunosorbent assay (ELISA) 46176
Image 2 URLSource image

title: Enhancing the breadth of protection in mice with a multivalent influenza vaccine
authors: Xiang Wang; Yixin Niu; ...; Dongming Zhou
journal: Communications Biology
date: 2026-01-07
pmid: 41501378
cited_by_count: 0
techniques: Conjugation Assay; Flow Cytometry; Incubation; Software; Staining
bioz_score: 94

title: Influence of SLAM Family Receptors in the NK-Cell-Mediated Surveillance of Lymphoblastic Acute Leukemia.
authors: Jacqueline Sánchez-Herrera; Lucero Valenzuela-Vázquez; ...; Mario Ernesto Cruz-Muñoz
journal: European Journal of Immunology
date: 2025-08-04
pmid: 40755061
doi: 10.1002/eji.70014
cited_by_count: 0
techniques: Flow Cytometry; Incubation; Recombinant; Sterility
bioz_score: 94

title: Durability of Functional SARS-CoV-2-Specific Immunological Memory and T Cell Response up to 8–9 Months Postrecovery From COVID-19
authors: Diptee Trimbake; Dharmendra Singh; ...; Anuradha S. Tripathy
journal: Journal of immunology research
date: 2025-01-01
doi: 10.1155/jimr/9743866
pmcid: 11832264
cited_by_count: 2
techniques: Cell Culture; Isolation; Recombinant; Recombinase Polymerase Amplification; Staining
bioz_score: 94

title: ARI0003: Co-transduced CD19/BCMA Dual-targeting CAR-T Cells for the Treatment of Non-Hodgkin Lymphoma.
authors: Mireia Bachiller; Nina Barceló-Genestar; ...; Sonia Guedan
journal: Molecular therapy : the journal of the American Society of Gene Therapy
date: 2024-11-19
pmid: 39563035
doi: 10.1016/j.ymthe.2024.11.028
cited_by_count: 15
techniques: Expressing; Flow Cytometry; Incubation; Recombinant; Recombinase Polymerase Amplification; Software; Staining
bioz_score: 94

Reviews

Write Your Own Review
You're reviewing:Anti-CD19 (Research Grade Denintuzumab Biosimilar) sinobiological 68215-H001
Your Rating
Copyright © 2025 Biogege, Inc. All rights reserved.